Skip to main content

RHUMBLINE ADVISERS

Position in NBIX — Neurocrine Biosciences Inc

CIK 1115418 BOSTON, MA

Position in NBIX

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$40,025,246
-$2,161,236 QoQ
Shares Held
303,820
+2.1% QoQ
Ownership
0.302%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 52.52024224869989.ToString("F0")% Shared 0.ToString("F0")% None 47.47975775130011.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

RHUMBLINE ADVISERS holds $438,094,582 across 50 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (9.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 NBIX
Neurocrine Biosciences Inc
This page
303,820 $40,025,246

All Filings in NBIX

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $40,025,246 303,820
2025-12-31 $42,186,482 297,444
2025-09-30 $42,606,733 303,510
2025-06-30 $38,862,091 309,190
2025-03-31 $34,782,151 314,486
2024-12-31 $43,745,247 320,478
2024-09-30 $37,071,689 321,747
2024-06-30 $44,644,728 324,288
2024-03-31 $44,424,997 322,107
2023-12-31 $42,020,899 318,920
2023-09-30 $36,620,212 325,513
2023-06-30 $30,959,350 328,307
2023-03-31 $31,033,444 306,594
2022-12-31 $35,831,761 299,998
2022-09-30 $30,530,064 287,450
2022-06-30 $27,141,843 278,435
2022-03-31 $23,931,000 255,264
2021-12-31 $21,709,833 254,900
2021-09-30 $24,079,452 251,063
2021-06-30 $24,523,569 251,989
2021-03-31 $24,717,157 254,161
2020-12-31 $10,891,339 113,629
2020-09-30 $11,532,372 119,929
2020-06-30 $15,589,282 127,781
2020-03-31 $8,694,639 100,458